taken from Small Gland, Big Problem 4th Edition
by Professor Roger Kirby, Health Press 2011

In the future, it may be possible to prevent prostate cancer. The benefits of the 5-alpha-reductase inhibitor Avodart (dutasteride) have been assessed in the large REDUCE trial, which showed a 23% reduction in prostate cancer diagnosed on biopsy. Several other agents, such as statins which are currently used to lower cholesterol, appear to show promise, but require further research to ensure their safety and effectiveness.